HOME >> MEDICINE >> NEWS
NIAID media availability: Understanding influenza infection

WHAT: The current flu season is underway and much attention is focused on the recent outbreaks of a deadly avian influenza virus in Asia and southeastern Europe. Understanding how influenza viruses cause infection and how the human immune system attempts to fight off the invaders offers a basis for developing new influenza vaccines and treatments that could potentially combat seasonal influenza or worse, a global pandemic.

In a commentary appearing online Jan. 17 in Immunity, National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony S. Fauci, M.D., and leading NIAID influenza vaccine researchers Brian R. Murphy, M.D., and Kanta Subbarao, M.D., M.P.H., discuss

  • How influenza viruses function
  • Why the human immune system effectively wards off flu infection in some cases but not others
  • The difference between antigenic "drift" and "shift"
  • The scenario that could create a flu pandemic
  • The practical and immunological challenges to developing protective vaccines

'"/>

Contact: Kathy Stover
kstover@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
17-Jan-2006


Page: 1

Related medicine news :

1. NIAID releases MDR/XDR Tuberculosis research agenda
2. NIAID DNA vaccine for H5N1 avian influenza enters human trial
3. NIAID media availability: Examining genetic variability of malaria parasite offers insight
4. NIAID awards $4 million to develop anti-radiation treatments
5. Partnership between NIAID and Sequella yields promising new TB drug for clinical testing
6. NIAID announces leadership for newly restructured HIV/AIDS clinical trials networks
7. NIAID study finds higher dose of flu vaccine improves immune response in the elderly
8. NIAID media availability: New study describes key protein from highly pathogenic H5N1 avian flu virus and how it might mutate
9. NIAID researchers show how promising TB drug works
10. NIAID awards $47 million to develop medical countermeasures against radiological, nuclear threats
11. NIAID launches first Phase II trial of a global HIV/AIDS vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2018)... ... ... Saturday, September 1st, 2018, Team Fastrax™ will perform their fan favorite patriotic ... At 7pm, the Cyclones will kick off against the South Dakota State Jackrabbits. Just ... jump in with their majestic 2,000 sq. ft. American Flag, red white and blue ...
(Date:8/31/2018)... ... August 31, 2018 , ... ... a small molecule drug discovery and development firm based in the Frederick ... to develop a first-in-class therapeutic targeting rare immune-mediated blood disorders, beginning with ...
(Date:8/29/2018)... ... August 29, 2018 , ... ... announced a new immunization module that allows independent pharmacies to start or ... all-time lows, service-oriented independent pharmacies are moving toward providing immunization programs in ...
(Date:8/29/2018)... ... August 29, 2018 , ... The Vape Mall has ... to provide information on the similarities and differences between smoking and vaping. , ... more importantly, differences between vaping and smoking. To accurately inform consumers on both ...
(Date:8/29/2018)... ... August 29, 2018 , ... National Senior Citizens Day ... when the facility was recognized for outstanding service by a proclamation from the ... August 21st ceremony by United Healthcare’s Angie Martinez, who nominated Pathways Memory Care ...
Breaking Medicine News(10 mins):
(Date:9/13/2018)... (PRWEB) , ... September 13, 2018 , ... ... is now available to test and ensure correct implementation of the NCPDP ... SCRIPT Version 2017071 includes important functionality and transactions identified by the industry as ...
(Date:9/12/2018)... (PRWEB) , ... September 12, 2018 , ... ... + Revenue Cycle Conference in Chicago, IL, from September 19-22. The IT + ... value of patient engagement and empowerment with the use of Precision Virtual Reality™ ...
(Date:9/7/2018)... ... September 06, 2018 , ... This year, the California Society of ... his presentation of: IDEAL IMPLANT® - Seven-Year Clinical Trial Results at the 68th CSPS ... at the upcoming ASPS (American Society of Plastic Surgeons) meeting in Chicago this fall. ...
Breaking Medicine Technology:
Cached News: